Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength of Intact Bones in Adult Male Rats
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength of Intact Bones in Adult Male Rats
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-23
DOI
10.1038/srep15632
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Systemic administration of sclerostin monoclonal antibody accelerates fracture healing in the femoral osteotomy model of young rats
- (2015) Gao Feng et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Sclerostin monoclonal antibody enhanced bone fracture healing in an open osteotomy model in rats
- (2014) Pui Kit Suen et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extracorporeal Shockwave Therapy for Treatment of Delayed Tendon-Bone Insertion Healing in a Rabbit Model
- (2012) Dick Ho Kiu Chow et al. AMERICAN JOURNAL OF SPORTS MEDICINE
- Sclerostin antibody inhibits skeletal deterioration due to reduced mechanical loading
- (2012) Jordan M Spatz et al. JOURNAL OF BONE AND MINERAL RESEARCH
- A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy
- (2012) Ge Zhang et al. NATURE MEDICINE
- Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: A drill-hole defect model
- (2011) Yi-Xin He et al. BONE
- Sclerostin antibody increases bone mass by stimulating bone formation and inhibiting bone resorption in a hindlimb-immobilization rat model
- (2010) XiaoYan Tian et al. BONE
- Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats
- (2010) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
- (2010) Desmond Padhi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bones
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Relation of age, gender, and bone mass to circulating sclerostin levels in women and men
- (2010) Ulrike I Mödder et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
- (2010) Carol Kilkenny et al. PLOS BIOLOGY
- Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis*
- (2008) Xiaodong Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis
- (2006) Carolyn M. Klotzbuecher et al. JOURNAL OF BONE AND MINERAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More